sb 203580 has been researched along with nu 6140 in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (nu 6140) | Trials (nu 6140) | Recent Studies (post-2010) (nu 6140) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 12 | 0 | 11 |
Protein | Taxonomy | sb 203580 (IC50) | nu 6140 (IC50) |
---|---|---|---|
Aurora kinase A | Homo sapiens (human) | 0.067 | |
Cyclin-T1 | Homo sapiens (human) | 5.1 | |
Cyclin-dependent kinase 1 | Homo sapiens (human) | 5.8 | |
Cyclin-dependent kinase 4 | Homo sapiens (human) | 0.94 | |
G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 5.8 | |
Interferon-induced, double-stranded RNA-activated protein kinase | Homo sapiens (human) | 2 | |
G1/S-specific cyclin-D1 | Homo sapiens (human) | 0.94 | |
G1/S-specific cyclin-E1 | Homo sapiens (human) | 1.1 | |
Cyclin-dependent kinase 2 | Homo sapiens (human) | 0.75 | |
Cyclin-dependent kinase 7 | Homo sapiens (human) | 2.3 | |
Cyclin-dependent kinase 9 | Homo sapiens (human) | 5.1 | |
Cyclin-H | Homo sapiens (human) | 2.3 | |
CDK-activating kinase assembly factor MAT1 | Homo sapiens (human) | 2.3 | |
Cyclin-dependent-like kinase 5 | Homo sapiens (human) | 8.8 | |
Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | 8.8 | |
Aurora kinase B | Homo sapiens (human) | 0.035 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A | 1 |
1 other study(ies) available for sb 203580 and nu 6140
Article | Year |
---|---|
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase | 2013 |